Mitochondrial Metabolism and Hepatic Complications of Obesity
NCT ID: NCT03302481
Last Updated: 2021-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2017-01-31
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fatty Liver and Ectopic Fat in Overweight and Obese Patients
NCT00886301
Non-invasive Evaluation of Hepatic Fibrosis in Patients With the Metabolic Syndrome
NCT00399932
Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease
NCT00949403
Study Visceral Adipose Tissue and Liver Stifness in a Retrospective Cohort of Diabetes Mellitus Patients
NCT04493814
Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease
NCT02422238
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Group
the biopsies will be performed under laparoscopy and taken in the lower part of the right hepatic lobe
liver biopsy
the biopsies will be performed under laparoscopy and taken in the lower part of the right hepatic lobe
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
liver biopsy
the biopsies will be performed under laparoscopy and taken in the lower part of the right hepatic lobe
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* affiliated to a social security
* candidate for laparoscopic obesity surgery
Exclusion Criteria
* Chronic viral hepatitis B or C
* Genetic hemochromatosis
* Taking the following drugs for at least 3 months up to 6 months before the scheduled date of obesity surgery: systemic corticosteroids, amiodarone, methotrexate
* Wilson's disease
* autoimmune hepatitis
* alpha 1-antitrypsin deficiency
* abetalipoproteinemia
* Contraindications to liver biopsy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David JACOBI, Dr
Role: PRINCIPAL_INVESTIGATOR
Nantes University Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC17_0055
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.